Market revenue in 2023 | USD 17.9 million |
Market revenue in 2030 | USD 30.4 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 67.04% in 2023. Horizon Databook has segmented the Latin America biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America is one of the fastest growing regions for the medical device outsourcing market owing to cost-effectiveness and rise in the number of new entrants venturing into the medical device market within the region. Brazil, Mexico, Colombia, Venezuela, and Argentina are driving the growth of the medical device market in Latin America.
The market is expected to showcase significant growth during the forecast period owing to increase in the number of medical device companies venturing into this region, which is anticipated to drive the demand for regulatory and quality assurance, thereby contributing to the growth of the medical device outsourcing market. In addition, its geographic placement being strategically close to the U.S. market is another factor boosting outsourcing to this region.
Presence of CROs and regulatory service providers is also expected to considerably increase, which is expected to further drive the market growth during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America biological skin substitutes market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account